MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF CALGARY on August 10, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Adjuvant hormono-chemotherapy in operable breast cancer.
[Adjuvant chemotherapy within the framework of primary treatment of operable breast cancer (proceedings)].
Adjuvant systemic therapy for operable breast cancer.
Neoadjuvant chemotherapy in operable breast cancer.
Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy.
[Adjuvant chemotherapy in the primary treatment of breast cancer (proceedings)].
Adjuvant chemotherapy of breast cancer.
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Progress in adjuvant chemotherapy for breast cancer: an overview.
Trials of adjuvant chemotherapy in breast cancer.
Trials of adjuvant chemotherapy in breast cancer.
Levamisole as an adjuvant in cancer treatment.
Neoadjuvant chemotherapy in 126 operable breast cancers.
Adjuvant systemic therapy in breast cancer. Part II: Adjuvant chemotherapy.
Chemotherapy as an adjuvant to surgery in lung cancer.
Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.
Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
Adjuvant chemotherapy for node-negative breast cancer.
Adjuvant chemotherapy for early breast cancer.
Sequential combination chemotherapy in advanced breast cancer.
Combination chemotherapy in metastatic breast cancer.
Leucovorin in combination chemotherapy of breast cancer.
Chemotherapy as an adjuvant to surgery for colorectal cancer.
Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer.
Combination chemotherapy as an adjuvant treatment in operable breast cancer.
Prolonged cyclic combination chemotherapy with cyclophosphamide, methotrexate and fluorouracil was evaluated as adjuvant treatment to radical mastecto...
990KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Adjuvant hormono-chemotherapy in operable breast cancer.
[Adjuvant chemotherapy within the framework of primary treatment of operable breast cancer (proceedings)].
Adjuvant systemic therapy for operable breast cancer.
Neoadjuvant chemotherapy in operable breast cancer.
Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy.
[Adjuvant chemotherapy in the primary treatment of breast cancer (proceedings)].
Adjuvant chemotherapy of breast cancer.
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Progress in adjuvant chemotherapy for breast cancer: an overview.
Trials of adjuvant chemotherapy in breast cancer.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms